CN Patent

CN118974017A — 卡博替尼的l-(+)-酒石酸盐及其固体形式

Assigned to Synthon BV · Expires 2024-11-15 · 2y expired

What this patent protects

本发明涉及式(1)的卡博替尼化合物与L‑(+)‑酒石酸的盐的固体形式及其制备方法，

USPTO Abstract

本发明涉及式(1)的卡博替尼化合物与L‑(+)‑酒石酸的盐的固体形式及其制备方法，

Drugs covered by this patent

cabozantinib-s-malate (CABOZANTINIB S-MALATE)

Patent Metadata

Patent number: CN118974017A
Jurisdiction: CN
Classification: —
Expires: 2024-11-15
Drug substance claim: No
Drug product claim: No
Assignee: Synthon BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.